ATLAS / Macro Radar / Reporting / IMMX

Immix Biopharma, Inc. (IMMX) reporting calendar

Immix Biopharma, Inc. files periodic reports with the SEC as IMMX on Nasdaq. Atlas tracks 18 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
18 Jul 2026 – 2 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
7 May 2026
Reports on record
18

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 41 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open IMMX market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20267 May 202637 days0001493152-26-021764
10-K31 Dec 202525 Mar 202684 days0001493152-26-012714
10-Q30 Sep 20257 Nov 202538 days0001493152-25-021325
10-Q30 Jun 20258 Aug 202539 days0001641172-25-022829
10-Q31 Mar 20258 May 202538 days0001641172-25-009280
10-K31 Dec 202425 Mar 202584 days0001641172-25-000387
10-Q30 Sep 202412 Nov 202443 days0001493152-24-044787
10-Q30 Jun 202412 Aug 202443 days0001493152-24-031358
10-Q31 Mar 20249 May 202439 days0001493152-24-018458
10-K31 Dec 202329 Mar 202489 days0001493152-24-011975
10-Q30 Sep 202313 Nov 202344 days0001493152-23-040182
10-Q30 Jun 202311 Aug 202342 days0001493152-23-027844
10-Q31 Mar 202312 May 202342 days0001493152-23-016721
10-K31 Dec 202227 Mar 202386 days0001493152-23-009091
10-Q30 Sep 20229 Nov 202240 days0001493152-22-031101
10-Q30 Jun 202212 Aug 202243 days0001493152-22-022359
10-Q31 Mar 202213 May 202243 days0001493152-22-013365
10-K31 Dec 202128 Mar 202287 days0001493152-22-007921

Source: SEC EDGAR company submissions for CIK 0001873835. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.